Compare SPDR Gold Trust (GLD) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? SPDR Gold Trust trades at $384.71 (market cap $139.66B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.71 (market cap $2.27B). The key difference: SPDR Gold Trust is far larger — about 61.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals.
| GLD | SLS | |
|---|---|---|
Market Cap | $139.66B | $2.27B |
Volume | 9,544,773 | 4,179,659 |
52-Week High | $495.90 | $15.46 |
52-Week Low | $362.32 | $1.39 |
Typical Hold Time | 74 Days | — |
Sector | — | Health |
Enterprise Value | — | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD, the SPDR Gold Trust ETF, trades at $384.77 with a 2.37% daily gain amid bearish technical signals. The stock faces pressure from rising Treasury yields and Federal Reserve rate expectations, though recent weak employment data provided temporary support. Technical indicators show strong bearish momentum with moving averages signaling sell pressure, while oscillators remain neutral. The ETF is testing key resistance levels with support at $373-$377 and resistance at $380-$384.
The outlook remains cautious as gold faces headwinds from monetary policy tightening and dollar strength. While serving as a traditional inflation hedge, GLD's near-term performance depends on interest rate trajectory and safe-haven demand. Risks include further Fed hawkishness and declining institutional interest, though long-term diversification benefits persist for portfolio allocation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
